Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Harborside Inc. $HBOR.ca $HBORF Announces Upsize of Previously Announced Private Placement to C$27 Million $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 9:39 AM on Wednesday, January 20th, 2021
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564690/hub/Harborside_Inc2_logo.png
  • Upsized its previously announced brokered private placement for gross proceeds of approximately C$27 million

Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, is pleased to announce that it has upsized its previously announced brokered private placement of units (the “Units”) of the Company at a price of C$2.55 per SVS Unit (as defined below) for gross proceeds of approximately C$27 million (the “Offering”), representing an increase of C$7 million, due to excess demand.  ATB Capital Markets and Beacon Securities Limited are co-lead agents to the Offering (the “Agents”).

The Company has granted the Agents an option to sell up to an additional 15% of the Units in the Offering, exercisable in whole or in part at any time prior to closing of the Offering.

As previously announced, Entourage Effect Capital, LLC, one of the largest shareholders of Harborside, is participating in the Offering with approximately C$9.0 million in commitment.

Read More:https://agoracom.com/ir/HarborsideInc/forums/discussion/topics/753458-harborside-inc-announces-upsize-of-previously-announced-private-placement-to-c-27-million/messages/2299033#message

Gratomic $GRAT.ca Appoints Karl Trudeau as a Director and Head of Namibian Operations $NGC.ca $LLG.ca $GPH.ca $NOU.ca $NMI.ca #TODAQ

Posted by AGORACOM at 8:51 AM on Wednesday, January 20th, 2021
  • Karl brings to the Board his unique experiences in building and operating some of the most profitable graphite mines in the Western World.

Gratomic Inc. (“GRAT” or the “Company”) (TSX.V:GRAT)(OTCQB:CBULF)(FRANKFURT:CB82)(WKN:A143MR) announces the appointment of Karl Trudeau as a Director of the Company and Head of Namibian Operations.

Karl brings to the Board his unique experiences in building and operating some of the most profitable graphite mines in the Western World. Working for Imerys Graphite et Carbonne, he operated and optimized the Lac-Des-Îles graphite mine to become the most profitable mining operation in Quebec in 2014. An additional significant milestone was achieved with Imerys, through his role as Natural Graphite Operations Leader, where Karl was responsible for the construction and development of the Okanjande Graphite Mine in Namibia, Africa.

As the COO of Nouveau Monde Graphite, Karl made important contributions to the project including his work as a pioneer in the electrification of mining operations. As the world is changing, Gratomic will be a focused leader in making the necessary and important change of establishing carbon neutral operations. Karl brings with him the knowledge from previous projects, which will assist in making the Company’s Aukam Graphite Project a carbon neutral operation.

The strength of established working relationships on previous projects with Armando Farhate and Andre Bennet and having a strong track record of delivering to plan will be a key contributing factor to the success of the Aukam Graphite Project.

“I had the privilege of working directly with Karl in other Graphite projects and having him side by side at the Board of Directors of Gratomic will ensure we continue to improve our governance level,” said Armando Farhate, COO & Head of Graphite Marketing and Sales.

“On behalf of the Board of Directors, I am very pleased to welcome Karl to the Board. This step solidifies his role with the Company and represents a harbinger of the success to come in Gratomic’s future,” said Arno Brand, President & CEO of Gratomic Inc.

The appointment of Karl Trudeau as a director is subject to the approval of the TSX Venture Exchange.

Read More: https://agoracom.com/ir/Gratomic/forums/discussion/topics/753448-gratomic-appoints-karl-trudeau-as-a-director-head-of-namibian-operations/messages/2299015#message

Harborside $HBOR.ca $HBORF Announces C$20 Million Private Placement of Equity Units and Provides 2021 Outlook $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 6:35 PM on Tuesday, January 19th, 2021
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564690/hub/Harborside_Inc2_logo.png
  • 2020 Preliminary Results and 2021 Outlook also provided

Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, today announced a brokered private placement of units (the “Units”) of the Company (the “Offering”) at a price of C$2.55 per SVS Unit (as defined below) for gross proceeds of approximately C$20 million with approximately C$9.0 million of commitment from Entourage Effect Capital, LLC (“Entourage”), one of the largest shareholders of Harborside.

The Company has granted the Agents (as defined below) an option to sell up to an additional 15% of the Units in the Offering, exercisable in whole or in part at any time prior to closing of the Offering.

Each Unit issued to non-residents of the United States (an “SVS Unit”) will be comprised of one subordinate voting share of the Company (the “Subordinate Voting Shares”) and one Subordinate Voting Share purchase warrant (each a “Warrant”) of the Company. Each Warrant will be exercisable to acquire one Subordinate Voting Share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering (the “Closing Date”) at an exercise price of C$3.69 per Warrant Share, subject to adjustment and acceleration in certain events.

All investors that are considered residents of the United States under the United States Securities Exchange Act of 1934, will be issued units comprised of multiple voting shares of the Company (the “Multiple Voting Shares”) and Multiple Voting Share purchase warrants of the Company, which will be based on the same economic equivalency of each Multiple Voting Share converting into 100 Subordinate Voting Shares.

“We are continuing to expand our footprint in the robust California cannabis market, delivering our best-in-class service and the high-quality product selection that Harborside is known for,” said Matthew Hawkins, Chairman of Harborside. “California is one of the largest cannabis markets in the world and Harborside has more than a decade of market success for our team to build on. I would like to thank our current and new shareholders for their overwhelming support of our growth strategy. This additional capital will solidify our balance sheet and provide a platform for us to continue to consolidate in the California market through accretive M&A transactions.”

Read More: https://agoracom.com/ir/HarborsideInc/forums/discussion/topics/753428-harborside-inc-announces-c-20-million-private-placement-of-equity-units-and-provides-2021-outlook/messages/2298963#message

VIDEO – Valeo Pharma $VPH.ca $VPHIF Starts Off 2021 With A Bang As MDBriefcase Validates Key Ingredients In Its Immune System Support Product $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 5:57 PM on Tuesday, January 19th, 2021
Valeo Pharma (@valeo_pharma) | Twitter

Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.

This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies. 

This model has resulted in the following success:

  • $5.3M in revenues in the first 9 months of 2020 (ending July 31, 2020)
  • 9 products currently in the market with an annual estimated peak sales of $40M/year
  • 7 products in the pipeline with an annual estimated peak sales of $45M/year

In fact, capital markets confidence is so high that Valeo secured $8.6M in financing in the last half of the year with:

  • $6.9M Bought Deal financing at $1.20/shares
  • A $1.7M Oversubscribed debenture (non-convertible) 

If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.

But then came Redesca.  We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH.  The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-30% of this market.  If you’re doing back of napkin math, that equates to $30,000,000 – $60,000,000 per year in revenues.

But how does a new product capture that much market share?  Glad you asked because we asked CEO Steve Saviuk the same question.  Competition is tough in all markets and they don’t let someone take 15-30% market share without one hell of a fight. 

Saviuk agreed and gave the following reasons:

1.  Redesca has an 8-year international track record of safety and efficacy.  It is already well known

2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.  

Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”

Well there you have it.  Valeo is a great story. Watch the video.

HOLD ON. THERE’S MORE … A LOT MORE

In a recently issued newsletter by MDBriefCase entitled “Exploring Novel Therapeutic Approaches for Covid-19: Hesperidin vs Vitamin C” the newsletter stated that recently accumulated evidence suggests that Hesperidin supplementation may be useful as a prophylactic agent against SARS-Cov-2 infection and as a complementary treatment during COVID-19 disease.  What does this mean?

  • Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process
  • Hesperidin may help against Covid-19 viral replication
  • Hesperidin is a potent antioxidant with anti-inflammatory activity that may help in controlling cytokine storm (where the body starts to attack its own cells and tissue rather than just the virus)
  • Valeo’s unique Hesperidin formulation (HESPERCO) is the only format available where every capsule contains 500mg of concentrated Hesperidin.

Now you have it.  That’s the Valeo story as it applies to just 2 of their amazing products.  There is a whole lot more to the story given their pipeline of products but we couldn’t cover it all in this great interview with CEO Steve Saviuk.

If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.

Victory Square $VST.ca $VSQTF Technologies Signs Binding Letter of Intent to Acquire IV Hydreight, An On-Demand & On-Site Mobile #Health, #Pharmaceutical & #Wellness Service Provider Across the United States $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 9:19 AM on Tuesday, January 19th, 2021
Victory Square Technologies | LinkedIn
  • Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.

  • In addition to providing telehealth services, Hydreight also provides a diverse suite of health & wellness protocols that include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments.

  • Hydreight is a USA certified e-script and telemedicine provider, allowing Hydreight to offer a wide array of health and medical services in all 50 states.

  • Hydreight provides full pharmaceutical offerings across the United States (Hydreight has full 503B Pharmaceutical supply capabilities ).
  • Hydreight has established key relationships and supply network chains with major vendors including: Medline, Mckesson, Allergan (Botox), Galderma and numerous pharmacies.

VANCOUVER, British Columbia, Jan. 19, 2021 — Victory Square Technologies Inc. (” Victory Square ” or the “ Company ”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that it has signed a binding letter of intent (the “ LOI ”) dated January 13, 2021 in respect of the acquisition (the “ Acquisition ”) of all of the shares of IV Hydreight Inc. (“ Hydreight ”), a mobile health and wellness service provider operating in the United States.

Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance. The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753355-victory-square-technologies-signs-binding-letter-of-intent-to-acquire-iv-hydreight-an-on-demand-on-site-mobile-health-pharmaceutical-wellness/messages/2298763#message

FansUnite $FANS.ca $FUNFF Enters into Partnership with OneComply to Assist with U.S. Licensing Strategy $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 7:56 AM on Tuesday, January 19th, 2021
  • FansUnite Entertainment Inc. and Vancouver-based OneComply Inc. have entered into a partnership. OneComply, a compliance and licensing solution, will assist FansUnite as they enter additional North American legalized gaming jurisdictions by advising on protocol and strategy.
  • This move follows the June 2020 announcement by FansUnite of the amalgamation with Vancouver-based Askott Entertainment Inc. to create one of Canada’s leading online gaming companies, focused on sports betting, esports wagering, and casino games.

Vancouver, British Columbia–(January 19, 2021) –  FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”) and Vancouver-based OneComply Inc. (“OneComply”) have entered into a partnership. OneComply, a compliance and licensing solution, will assist FansUnite as they enter additional North American legalized gaming jurisdictions by advising on protocol and strategy.

This move follows the June 2020 announcement by FansUnite of the amalgamation with Vancouver-based Askott Entertainment Inc. to create one of Canada’s leading online gaming companies, focused on sports betting, esports wagering, and casino games.

“We are pleased to be partnering with OneComply as we look to tackle the North American gaming market,” said Scott Burton, CEO of FansUnite. “As a licensed betting and iGaming company, we understand how difficult and nuanced the licensing process can be. With the help of OneComply, we will be able to streamline the process to enter new North American markets and showcase our suite of gaming solutions to a broader audience.”

The repeal of PASPA, being the Professional and Amateur Sports Protection Act, has created a wave of newly regulated States across the United States’ gaming market. Companies seeking to gain market entry into these States face massive regulatory processes to obtain operational licenses. The United States legalized gaming industry is State-regulated, meaning companies need to file for each jurisdiction independently. These individual disclosure filings can be thousands of pages in size resulting in substantial internal and external expenses.

“The amount of opportunity in North America for new-to-market companies can be overwhelming given the various licensing processes and jurisdictional requirements, with companies no longer trying to enter one jurisdiction, but multiple jurisdictions simultaneously. This creates a tremendous amount of lag in productivity even with the most seasoned of compliance and legal teams,” said Cameron Conn, CEO of OneComply Inc. “We understand the importance FansUnite places on regulation, and we look forward to supporting them scale in the North American market.”

Read More: https://agoracom.com/ir/FansUniteEntertainment/forums/discussion/topics/753353-fansunite-enters-into-partnership-with-onecomply-to-assist-with-u-s-licensing-strategy/messages/2298761#message

Candente Gold Changes Name to Xali Gold Corp. $XGC.ca $FMG.ca $MEX.ca $AGI.ca $DSV.ca

Posted by AGORACOM at 6:16 PM on Monday, January 18th, 2021

Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased to announce that the Company will change its name to Xali Gold Corp. on Tuesday January 19th, 2021. The new trading symbol will be XGC, CUSIP number will be 98387F103 and ISIN will be CA98387F1036. The website will also be changed to www.xaligold.com.

About Xali Gold
Xali Gold has launched a comprehensive growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset and an integral part of the overall growth strategy. The acquisition of the SDA Plant, the El Dorado historic mines and the Cocula Project signify important initial steps.

The financial benefits from Western Mexico operations and the addition of specialized personnel will translate across platforms to strengthen the Company’s efforts to explore and potentially mine areas demonstrated to contain mineralization of value. The Company is currently evaluating other properties that are complementary to the SDA plant, El Dorado and the Cocula Project.

Read More: https://agoracom.com/ir/XaliGold/forums/discussion/topics/753330-candente-gold-changes-name-to-xali-gold-corp/messages/2298688#message

‘Ensure that your diet is 90% to 100% plant-based’: 9 food rules from the world’s longest-living people SPONSOR: PlantX Life $VEGA.ca $PLTXF $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 1:39 PM on Monday, January 18th, 2021

SPONSOR: PlantX Life (VEGA:CSE) (PLTXF:OTCQB)

The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.

PlantX Life (VEGA:CSE) (PLTXF:OTCQB) Is The One Stop Shop For Everything Plant Based + The  Digital Face of The Plant -Based Community with the following:

  • Plant Based Meal Delivery (20 meals)
  • Plant Based Snack Products
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
  • Plant Based Recipes
  • Plant Based Essentials …. Like Chocolate (Essential?  You Bet)
  • And …… Plant Based …. PLANTS (It’s A BIG Business!)

More than just talk, VEGA is already in full swing and growing FAST

  • Already Operating In Canada
  • US Online Operations Kick Off With $USD 25M MIN of PlantX products YEAR 1
    • 6% Royalty Fee to PlantX on gross USA revenues
  • £8 million Acquisition of Bloombox In The UK, generating millions in revenue
  • Closed $11.5M Non-Brokered Private Placement
  • Monthly gross revenue of over $1M for December 2020
  • · ….. and just announced its Application To List On NASDAQ

Hub On AGORACOM / Corporate Profile

‘Ensure that your diet is 90% to 100% plant-based’: 9 food rules from the world’s longest-living people

By: Dan Buettner, Contributor

More than 15 years ago, I set out to reverse-engineer a formula for longevity. Working with renowned doctors and nutritionists, I identified several Blue Zones: Places around the world where people live the longest.

Along the way, I met experts who helped me understand why the foods people ate led to longer lives. We also distilled 150 dietary surveys of centenarians, or those who live to 100 or longer, to reveal the secrets of a strong longevity regimen.

These nine simple guidelines reflect what foods (and how of much of it) Blue Zone residents eat to stay healthy:

1. Ensure that your diet is 90% to 100% plant-based.

Centenarians eat an impressive variety of garden vegetables and leafy greens (especially spinach, kale, beet and turnip tops, chard and collards) when they are in season.

During the off-season, they pickle or dry the surplus. Beans, greens, sweet potatoes, whole grains, fruits, nuts and seeds dominate Blue Zone meals all year long.

Olive oil is also a staple. Evidence shows that olive oil consumption increases good cholesterol and lowers bad cholesterol. In the Greek island Ikaria, for example, we found that for middle-aged people, about six tablespoons of olive oil daily seemed to cut the risk of premature mortality by 50%.

2. Retreat from meat.

On average, Blue Zone residents eat about two ounces or less of meat about five times per month (usually as a celebratory food, a small side, or as a way to flavor dishes).

One 12-year study, which followed a community of 96,000 Americans in Loma Linda — a Blue Zone region in California — determined that people who lived the longest were vegans or pesco-vegetarians who ate a small amount of fish.

Vegetarians in Loma Linda, according to the researchers, were more likely to outlive their meat-eating counterparts by as many as eight years.

Okinawans in Japan probably offer the best meat substitute: Extra-firm tofu, which is high in protein and cancer-fighting phytoestrogens.

3. Go easy on fish.

In most Blue Zones, people ate small amounts of fish, fewer than three ounces up to three times weekly.

Usually, the fish being eaten are small, relatively inexpensive varieties like sardines, anchovies and cod —species in the middle of the food chain that are not exposed to the high levels of mercury or other chemicals that pollute our gourmet fish supply today.

Again, fish is not a necessary part of a longevity diet, but if you must eat it, elect varieties that are common and not threatened by overfishing.

4. Eat a daily dose of beans.

Beans reign supreme in Blue Zones and are the cornerstone of every longevity diet in the world: Black beans in Nicoya; lentils, garbanzo and white beans in the Mediterranean; and soybeans in Okinawa.

Most centenarians eat at least four times as many beans as Americans do on average — at least a half cup per day. And so should you. Why? Beans are packed with more nutrients per gram than any other food on Earth.

On average, they are made up of 21% protein, 77% complex carbohydrates, and only a few percent fat. Because they are fiber-rich and satisfying, they’ll likely help to push less healthy foods out of your diet.

5. Slash sugar.

Blue Zone communities eat sugar intentionally, not by habit or accident.

They consume about the same amount of naturally occurring sugars as North Americans do, but only about a fifth as much added sugar — no more than seven teaspoons a day.

Between 1970 and 2000, the amount of added sugar in the American food supply rose by 25% (about 22 teaspoons of added sugar per day) — generally, the result of the insidious, hidden sugars mixed into soda, yogurt and sauces.

If you must eat sweets, save cookies, candy and bakery items for special occasions (ideally as part of a meal). Limit sugar added to coffee, tea or other foods to no more than four teaspoons per day.

Skip any product that lists sugar among its first five ingredients.

6. Snack on nuts.

Eat two handfuls of nuts per day.

A handful weighs about two ounces, the average amount that Blue Zone centenarians consume: Almonds in Ikaria and Sardinia, pistachios in Nicoya, and all varieties of nuts with the Adventists in Loma Linda.

A study on food and longevity found that nut eaters outlive non-nut eaters by an average of two to three years. So try to snack on a couple handfuls of almonds, Brazil nuts, cashews, walnuts, or peanuts every day.

7. Sour on bread.

If you can, strive to eat only sourdough or 100% whole wheat bread.

Most commercially available breads start with bleached white flour, which metabolizes quickly into sugar and spikes insulin levels.

But bread in Blue Zones is either whole grain or sourdough. In Ikaria and Sardinia, breads are made from a variety of whole grains such as wheat, rye or barley, each of which offers a wide spectrum of nutrients.

Whole grains have higher levels of fiber than most commonly used bleached flours. Some traditional Blue Zone breads are made with naturally occurring bacteria called lactobacilli, which “digest” the starches and glutens while making the bread rise.

The process also creates an acid — the “sour” in sourdough. The result is bread with less gluten than breads labeled “gluten-free,” with a longer shelf life and a pleasantly sour taste that most people like.

8. Drink mostly water.

If possible, strive to avoid soft drinks, including diet soda. With very few exceptions, people in Blue Zones drink only coffee, tea, water and wine.

(Soft drinks, which account for about half of Americans’ sugar intake, were unknown to most Blue Zone centenarians until recently.)

Here’s why:

  • Water: Adventists recommend seven glasses of water daily. They point to studies showing that being hydrated facilitates blood flow and lessens the chance of a blood clot.
  • Coffee: Sardinians, Ikarians, and Nicoyans all drink coffee. Research associates coffee with lower rates of dementia and Parkinson’s disease.
  • Tea: Okinawans prefer green varieties, which have been shown to lower the risk of heart disease and several cancers. Ikarians drink brews of rosemary, wild sage and dandelion — all herbs known to have anti-inflammatory properties.
  • Red Wine: People who drink — in moderation — tend to outlive those who don’t. (This doesn’t mean you should start drinking if you don’t drink now.) People in most Blue Zones drink one to three small glasses of red wine per day, often with a meal and with friends.

9. Go whole.

We found that most centenarians traditionally eat whole foods.

These are foods made from single ingredient — raw, cooked, ground or fermented — and are not highly processed. They eat raw fruits and vegetables; they grind whole grains themselves and then cook them slowly.

They also use fermentation — an ancient way to make nutrients bioavailable — in the tofu, sourdough bread, wine and pickled vegetables they eat.

And they rarely ingest artificial preservatives. Blue zones dishes typically contain a half dozen or so ingredients, simply blended together.

Dan Buettner is a longevity researcher, National Geographic Fellow and award-winning journalist. He is the author of “The Blue Zones Solution” His latest bestseller, “The Blue Zones Kitchen,” fuses scientific reporting, National Geographic photography and recipes that may help you live to 100. Follow him on Instagram @DanBuettner.

Source: https://www.cnbc.com/2020/12/10/90-to-100-plant-based-diet-food-longevity-secrets-from-people-who-live-to-100-or-longer.html

Tartisan Nickel $TN.ca: Poised For A Breakout Year! Resource Expansion & Exploration Ramp Up IS Coming IN 2021 $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca $FPC.ca $NICO.ca

Posted by AGORACOM at 10:33 AM on Monday, January 18th, 2021
Tc logo in black

Morgan Stanley on Nickel Forecast:

  • 6.4% demand growth in 2021
    • outpacing supply as Indo NPI growth offset by China’s decline
  • Market moving from 85kt surplus in 2020 to -18kt in ’21
    • Supporting average price of $7.29/lb, with risk skewed to bull case $8.75/lb

Tartisan Investment Highlights:

  • Kenbridge Nickel Deposit is a Class 1 Nickel project which can safely be put into production quickly at low capital cost
  • Updated Mineral Resource Estimate: 7.47 Ktonnes 0.6% Ni, 0.32% Cu open pit and underground
  • Measured and Indicated resources 985 Ktonnes Inferred at 1% Ni, 0.62% or 117 million pounds of Nickel and 66 million pounds of Copper
  • Potential to double the underground resource at Kenbridge through anticipated drill program
  • Kenbridge North – Untested Potential to Discover additional Class 1 Deposits

Tartisan Strategic Investment Holdings $9+ Million

  • Eloro Resources,  Class One Nickel and Technologies , Peruvian Metals Corp. provide Tartisan shareholders an opportunity to participate in other high-quality projects

Kenbridge Ni Project (Kenora, Ontario)

  • Property is accessible via gravel roads from paved Highway 71
  • Underground development of the deposit extends from surface to a depth of 623 metres in a 3 compartment shaft, with 244 metres of drifts and 168 metres of crosscuts at the 110 and 150 metre levels
  • The minimum drill spacing is at 15.2metres on all levels.
  • The deepest hole extends to 838.4 metre depth and intersected mineralization grading 4.25% nickel and 1.38% copper over 10.7 metres, indicating that the deposit remains open at depth.
  • Historical surface drilling was completed at 30.5metre spacing
  • Preliminary  Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits

Look for Tartisan Corporate updates in 2021 at Tartisan.com

XPhyto $XPHY.ca Announces Business Strategy and Milestones For 2021 Innovation to Impact $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 7:41 AM on Monday, January 18th, 2021
  • Commercialization of rapid COVID-19 PCR test
  • Clinical validation of transdermal and sublingual drug formulations
  • Psychedelic API production, drug formulation and clinical integration

XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company“) is pleased to announce its business strategy and milestones for 2021. The Company is on the cusp of transformational change as product development programs advance from the laboratory to the clinic. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto will target growth through commercialization of existing products and focused investment in impact driven innovation with the potential for extreme value creation.

The Company will continue to leverage its scientific expertise and operations in Europe and North America for product development and optimization while it plans to add significant commercial experience in the fields of manufacturing, distribution, marketing and sales. Following a successful business year 2020, XPhyto is well positioned to execute on important core milestones in all business divisions, which include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment and development in psychedelic medicine.

Diagnostics

XPhyto’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system which is secured under an exclusive global commercialization agreement from its German development partner, 3a-diagnostics GmbH (“3a”). PCR testing has emerged as the only internationally recognized standard for COVID-19 testing, which is expected to play a critical role in expediting the revitalization of many industries, particularly domestic and international travel. Successful validation of the PCR system was achieved in Q4 2020 and the Company is confident that European commercial (CE-IVD) approval will be achieved in Q1 2021. XPhyto is in discussions to secure manufacturing and distribution partners in Europe and the Middle East in anticipation of pending commercial approval and product launch in Q1 2021.

In addition to COVID-19 products, XPhyto and its partner 3a, are developing and commercializing a portfolio of low-cost oral biosensors. The Company’s lead biosensor product is an oral health screening test for the detection of peri-implantitis. There is a significant clinical need for the early detection of infection associated with dental implants prior to the onset of irreversible tissue and bone damage. The company is targeting late 2021 for European commercial approval and product launch for several biosensor screening tests.

Drug Formulations and Delivery

XPhyto’s drug formulation business is focused on neurological indications with significant market demand and the potential for meaningful patient impact. In 2020, XPhyto’s German subsidiary, Vektor Pharma TF GmbH (“Vektor”), a leader in the development of transdermal and sublingual drug formulations reported significant advancements in four therapeutic development programs. Vektor also successfully developed a sublingual drug formulation on contract for a major generic drug manufacturer and distributor.

In 2021, the Company plans to complete human pilot studies on its four lead therapeutic products: 1) Rotigotine transdermal patch for Parkinson’s disease; 2) CBD oral/sublingual strip for treatment resistant Epilepsy; 3) THC oral/sublingual strip for anorexia/nausea; and 4) CBD:THC (1:1) oral/sublingual strip for Multiple Sclerosis associated spasticity. The Company is currently in ongoing discussions with multiple potential commercial partners, licensors and distributors and will be reviewing monetization opportunities on a continued basis.

Psychedelics

Psychedelic compounds are a highly promising new class of active pharmaceutical ingredient (“API”) with strong potential for the treatment of mental health related medical conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Psychedelics could provide a major improvement over currently available therapeutics for a global market with unmet medical need.

XPhyto has entered into two psychedelic agreements: first, for the development of industrial scale biotechnology processes for the production of psilocybin, and second, for research and development related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA, DMT, among others.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/753246-xphyto-announces-business-strategy-and-milestones-for-2021-innovation-to-impact/messages/2298545#message